For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230905:nRSE4754La&default-theme=true
RNS Number : 9033L Instem plc 08 September 2023
Amendment: Form 8 (OPD) - Instem plc
The following amended announcement corrects certain 'Latest Exercisable Dates'
in section 3(B) in the Form 8 (OPD) announcement released at 6.00 p.m. on 5
September 2023 (under RNS no. 4754L)
The full amended version is below:
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Instem plc
(b) Owner or controller of interests and short positions disclosed, if N/A
different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a
trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form Instem plc
relates:
Use a separate form for each offeror/offeree
(d) Is the discloser the offeror or the offeree? OFFEREE
(e) Date position held: 4 September 2023
The latest practicable date prior to the disclosure
(f) In addition to the company in 1(c) above, is the discloser making N/A
disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates
Class of relevant security:
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: Nil 0.00 Nil 0.00
(2) Cash-settled derivatives: Nil 0.00 Nil 0.00
(3) Stock-settled derivatives (including options) and agreements to Nil 0.00 Nil 0.00
purchase/sell:
Nil 0.00 Nil 0.00
TOTAL:
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
Class of relevant security in relation to which subscription right exists: None
Details, including nature of the rights concerned and relevant percentages: N/A
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO
THE OFFER MAKING THE DISCLOSURE
Details of any interests, short positions and rights to subscribe (including
directors' and other employee options) of any person acting in concert with
the party to the offer making the disclosure:
A) Holdings of ordinary shares by directors of Instem plc and their close
relatives:
Name No. Ordinary Shares Held % of total issued share capital carrying voting rights
David Gare* 1,326,865 5.79%
Phil Reason 770,714 3.36%
Nigel Goldsmith 10,000 0.04%
*Includes holdings of Deborah Walker and Michael Gare and shares held via DG
2008 Discretionary Settlement Trust (of which David Gare and Norma Gare are
trustees)
B) The directors of the Company have the following rights to subscribe for
the following relevant Instem plc securities under the share options plans:
Name Date of Grant Vesting period Latest Exercisable Date Exercise price (£) No. of options outstanding
Phil Reason 26/06/2020 3 years 15/03/2024 Nil 76,000
Phil Reason 16/04/2021 3 years 15/03/2025 Nil 4,387
Phil Reason 27/09/2021 3 years 15/03/2025 Nil 25,000
Phil Reason 02/03/2022 3 years 15/03/2026 Nil 4,833
Nigel Goldsmith 29/07/2015 3 years 28/07/2025 0.10 62,500
Nigel Goldsmith 22/02/2018 3 years 22/02/2028 Nil 80,000
Nigel Goldsmith 26/06/2020 3 years 26/06/2030 Nil 74,000
Nigel Goldsmith 16/04/2021 3 years 16/04/2031 Nil 3,031
Nigel Goldsmith 27/09/2021 3 years 27/09/2031 Nil 25,000
Nigel Goldsmith 02/03/2022 3 years 02/03/2032 Nil 2,165
*Includes holdings of Deborah Walker and Michael Gare and shares held via DG
2008 Discretionary Settlement Trust (of which David Gare and Norma Gare are
trustees)
B) The directors of the Company have the following rights to subscribe for
the following relevant Instem plc securities under the share options plans:
Name Date of Grant Vesting period Latest Exercisable Date Exercise price (£) No. of options outstanding
Phil Reason 26/06/2020 3 years 15/03/2024 Nil 76,000
Phil Reason 16/04/2021 3 years 15/03/2025 Nil 4,387
Phil Reason 27/09/2021 3 years 15/03/2025 Nil 25,000
Phil Reason 02/03/2022 3 years 15/03/2026 Nil 4,833
Nigel Goldsmith 29/07/2015 3 years 28/07/2025 0.10 62,500
Nigel Goldsmith 22/02/2018 3 years 22/02/2028 Nil 80,000
Nigel Goldsmith 26/06/2020 3 years 26/06/2030 Nil 74,000
Nigel Goldsmith 16/04/2021 3 years 16/04/2031 Nil 3,031
Nigel Goldsmith 27/09/2021 3 years 27/09/2031 Nil 25,000
Nigel Goldsmith 02/03/2022 3 years 02/03/2032 Nil 2,165
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the party to
the offer making the disclosure or any person acting in concert with it:
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the party to the offer making the disclosure, or any person acting in
concert with it, and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
(c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO
Supplemental Form 8 (SBL) NO
Date of disclosure: 8 September 2023
Contact name: Nigel Goldsmith, Chief Financial Officer
Telephone number: +44 17 8582 5608
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
(http://www.thetakeoverpanel.org.uk) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FEELVLFBXKLXBBK